• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Club Drugs and Novel Psychoactive Substances: The Clinician's Handbook

Club Drugs and Novel Psychoactive Substances: The Clinician's Handbook

9781911623090
163,74 zł
147,36 zł Zniżka 16,38 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 147,36 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.
Szczegóły produktu
89411
9781911623090
9781911623090

Opis

Rok wydania
2020
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
150
Wymiary (mm)
122.00 x 186.00
Waga (g)
160
  • Part I:: 1. Introduction 2. What are NPS and Club Drugs and why are they important; 3. A brief history of NPS production and distribution; 4. Drugs classification framework for Club Drugs and NPS; 5. Clinical challenge of Club Drugs and NPS; Part II. Stimulant Drugs; 6. Stimulant drugs:: introduction; 7. Stimulant drugs:: cocaine; 8. Stimulant drugs:: amphetamine-type; 9. Stimulant drugs:: methamphetamine; 10. Stimulant drugs:: MDMA; 11. Stimulant drugs:: synthetic cathinones; Part III. Depressant Drugs; 12. Depressant drugs:: introduction; 13. Depressant drugs:: GHB/GBL; 14. Depressant drugs:: Fentanyl, Fentanyl analogues and other opioid NPS; 15. Depressant drugs:: Benzodiazepine NPS; 16. Depressant drugs:: Ketamine and its anaologues; Part IV. Synthetic Cannabinoid Receptor Agonsits; 17. Synthetic cannabinoid receptor agonists (SCRAs); Part V. Hallucinogens; 18. Hallucinogens; Part VI. Concluding Remarks and References; 19. Concluding Remarks; 20. References.
Komentarze (0)